Meta‐Analysis of the Effect of MDR1 C3435T Polymorphism on Cyclosporine Pharmacokinetics
Authors:
- 14 October 2008
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 103 (5) , 433-444
Abstract
Abstract: The published data revealed conflicting results of the polymorphism of MDR1 exon 26 SNP C3435T on the pharmacokinetics of cyclosporine; thus, the aim was to conduct a meta‐analysis of significant magnitude to investigate the influence of SNP C3435T on the pharmacokinetics of cyclosporine. A literature search was conducted to locate the relevant papers by using the PubMed electronic source from 1997 and onwards. The pharmacokinetic parameters, including AUC0–4, AUC0–12, AUC0‐inf, Cmax, CL/F and trough concentration (C0), were extracted and a meta‐analysis was performed by using Stata version 9.1. A total of 14 papers concerning 1036 individuals were included in the meta‐analysis. The overall results showed no major influence of SNP C3435T on the pharmacokinetic parameters, including AUC0–4, AUC0‐inf, CL/F, Cmaxand C0, although AUC0–12was lower in subjects with CC genotype. A subanalysis by ethnic population showed that C0was lower in Caucasian individuals harbouring CC genotype. In conclusion, our meta‐analysis of available studies has thus far failed to demonstrate a definitive correlation between the SNP C3435T inMDR1gene and alterations in P‐glycoprotein function that can result in altered pharmacokinetics of cyclosporine, although it was indicated in this meta‐analysis that the carrier of CC genotype of the SNP C3435T of MDR1 had lower cyclosporine exposure presented as AUC0–12than those with at least one T allele. There seems to be ethnic differences in the relationship between the SNP C3435T of MDR1 and cyclosporine pharmacokinetics.Keywords
This publication has 40 references indexed in Scilit:
- Polymorphisms of Multidrug Resistance Gene (MDR1) and Cyclosporine Absorption in De Novo Renal Transplant PatientsTransplantation, 2007
- Effects of genetic polymorphisms on the pharmacokinetics of calcineurin inhibitorsAmerican Journal of Health-System Pharmacy, 2006
- Effect ofABCB1(MDR1) haplotypes derived from G2677T/C3435T on the pharmacokinetics of amlodipine in healthy subjectsBritish Journal of Clinical Pharmacology, 2006
- ABCB1 Genotype of the Donor but Not of the Recipient Is a Major Risk Factor for Cyclosporine-Related Nephrotoxicity after Renal TransplantationJournal of the American Society of Nephrology, 2005
- P‐glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowthJournal of Clinical Periodontology, 2004
- MDR1 Haplotypes Do Not Affect the Steady‐State Pharmacokinetics of Cyclosporine in Renal Transplant PatientsThe Journal of Clinical Pharmacology, 2003
- Amlodipine, but not MDR1 polymorphisms, alters the pharmacokinetics of cyclosporine A in Japanese kidney transplant recipients1Transplantation, 2003
- Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic–genotypic correlatesBritish Journal of Clinical Pharmacology, 2003
- CyclosporineNew England Journal of Medicine, 1989
- Intraindividual variability in the relative systemic availability of cyclosporin after oral dosingEuropean Journal of Clinical Pharmacology, 1988